Neurology
Browse by
The University of Nevada, Reno School of Medicine and Renown Health have joined forces to bring together the most advanced stroke and neurology care in the region through the Institute for Neurosciences. The Institute functions as the Department of Neurology for the School of Medicine, and provides the most innovative diagnostic and therapeutic services as well as teaching core neurology knowledge and skills to Nevada's future physicians. The Institute is dedicated to cutting-edge research aimed at advancing the discipline of neurology and providing state-of-the art treatments for neurological disorders while training residents and students on the most effective neurologic treatments and procedures.
Patients suffering from complex brain and nerve disorders including memory problems, stroke, migraines and epilepsy are given exceptional clinical care with the communication and support they need to improve their health. All of our doctors are skilled in treating neurological disorders and are the best resources to train and educate medical students, residents and fellows on revolutionary neuroscience medicine. Doctors educate students on how to exceed patient care expectations and to provide compassionate yet innovative medical support.
The physicians at the School of Medicine and Renown Health remain current on progressive research in the field of neurosciences and are continually developing new clinical trial treatment options. The Institute for Neurosciences is the only institute in Northern Nevada participating in clinical research. Neurology specialists have been active contributors to many exciting therapy developments including stroke prevention therapy, acute stroke therapy and Botox® for migraine prevention. For advanced medical attention to neurological disorders and innovative treatment options, seek the advice from the staff at the Institute for Neurosciences.
Theses and Dissertations for Neurology
Collections in this community
Recent Submissions
-
.
.
.
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical Trial
(Journal of the American Medical Association, 2016)Deutetrabenazine is a novel molecule containing deuterium, which attenuates CYP2D6 metabolism and increases activemetabolite half-lives and may therefore lead to stable systemic exposure while preserving key pharmacological ... -
.
.
.
Gastrointestinal Beriberi and Wernicke's Encephalopathy Triggered by One Session of Heavy Drinking
(Case Reports in Neurology, 2019)An otherwise healthy 30-year-old male acquired gastrointestinal beriberi and subsequent Wernicke's encephalopathy after 1 session of heavy drinking. Nausea, vomiting, and anorexia relentlessly progressed. The patient ... -
.
.
.
Reversible hand tremors, downbeat nystagmus, and an unsteady gait with nontoxic lithium level
(Clinical Case Reports, 2019)Key Clinical Message Patients with nontoxic lithium levels can still develop hand tremors, downbeat nystagmus, and an unsteady gait. -
.
.
.
SREAT presenting as decades of intractable seizures and isolated delusional episodes with clinical, laboratory, and EEG confirmation of treatment response
(SAGE Open Medical Case Reports, 2019)We report a case of a 60-year-old woman with a history of intractable seizures and isolated delusional psychosis who was later diagnosed with steroid-responsive encephalopathy associated with autoimmune thyroiditis. The ... -
.
.
.
Reversible dementia: subclinical seizure in early-onset dementia
(Clinical Case Reports, 2017)We report a case of early-onset dementia with subclinical seizures. Aggressive seizure control improved the patient's cognition. Commonly, an EEG is only performed following overt behavioral seizures. Therefore, subclinical ... -
.
.
.
Hashimoto's encephalopathy - presenting with epilepsia partialis continua and a frontal lobe lesion
(Clinical Case Reports, 2018)We report a case of Hashimoto's encephalopathy (HE), who presented with epilepsia partialis continua (EPC) and a frontal lobe lesion. The diagnosis of HE remained elusive until the serum thyroid antibodies became positive ...